Mylan to challenge court decision over generic asthma, COPD drug
Drug maker had sought approval for generic version of Sunovion's Xopenex
Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.
Post a Comment
Footer Content
Retail Group
Events - Retail
Industry Guides, Research & Reports
International
footer
© 2012 Drug Store News. All Rights Reserved.